Curtiss-Wright (NYSE: CW) director Larry Wyche receives $160,000 stock award
Rhea-AI Filing Summary
Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.
The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 128 | $624.93 | $80K |
Footnotes (1)
- Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected. The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share. This amount reflects 50% of the reporting person's annual restricted stock award. The reporting person has elected to defer receipt of the remaining 50% (i.e., 128 shares) of his annual restricted stock award to a later date. Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.
FAQ
What did Curtiss-Wright (CW) director Larry D. Wyche report on this Form 4?
How was the Curtiss-Wright (CW) stock grant for Larry D. Wyche calculated?
What are the vesting conditions on Larry D. Wyche’s Curtiss-Wright (CW) restricted stock?
Is this Curtiss-Wright (CW) Form 4 transaction a market purchase or sale?